120 related articles for article (PubMed ID: 2660898)
1. Cytokines regulate the ability of human LAK-cells to kill human tumour cells in vitro.
Gallagher G; al-Azzawi F; Davis J; Stimson WH
Br J Cancer; 1989 Jun; 59(6):919-21. PubMed ID: 2660898
[No Abstract] [Full Text] [Related]
2. Induction of human monocyte susceptibility to lymphokine-activated killer cell lysis by granulocyte-macrophage colony-stimulating factor.
Blanchard DK; Serbousek D; Djeu JY
Cancer Res; 1989 Sep; 49(18):5037-43. PubMed ID: 2670200
[TBL] [Abstract][Full Text] [Related]
3. Killing of alveolar macrophages and of monocytes that have responded to granulocyte-macrophage colony-stimulating factor by human lymphokine-activated killer cells.
Sone S; Inamura N; Singh SM; Okubo A; Yanagawa H; Nakanishi M; Ogura T
Jpn J Cancer Res; 1989 Jul; 80(7):662-9. PubMed ID: 2507489
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma-induced alterations of monocyte susceptibility to lysis by autologous lymphokine-activated killer (LAK) cells.
Djeu JY; Blanchard DK
Int J Cancer; 1988 Sep; 42(3):449-54. PubMed ID: 3138195
[TBL] [Abstract][Full Text] [Related]
5. The proliferation of AML-193 is regulated by multiple hematopoietic growth factors and cytokines.
Adams S; Upadhyaya G; Clarke MF; Emerson SG
Leukemia; 1989 Apr; 3(4):314-5. PubMed ID: 2648086
[No Abstract] [Full Text] [Related]
6. Interleukin-3 and interleukin-4 each strongly inhibit the induction and function of human LAK cells.
Gallagher G; Wilcox F; al-Azzawi F
Clin Exp Immunol; 1988 Nov; 74(2):166-70. PubMed ID: 3265653
[TBL] [Abstract][Full Text] [Related]
7. Physiology of granulocyte and macrophage colony-stimulating factors in host defense.
Weisbart RH; Golde DW
Hematol Oncol Clin North Am; 1989 Sep; 3(3):401-9. PubMed ID: 2483721
[TBL] [Abstract][Full Text] [Related]
8. Differential augmentation of in vivo natural killer cytotoxicity in normal primates with recombinant human interleukin-1 and granulocyte-macrophage colony-stimulating factor.
Davis TA; Monroy RL; Skelly RR; Donahue RE; MacVittie TJ
Clin Exp Immunol; 1990 Mar; 79(3):436-42. PubMed ID: 2180599
[TBL] [Abstract][Full Text] [Related]
9. Regulation of macrophage effector function by B cell stimulatory factor-1 (BSF-1).
Crawford RM; Finbloom DS; Ohara J; Paul WE; Meltzer MS
Adv Exp Med Biol; 1988; 239():223-9. PubMed ID: 3059765
[No Abstract] [Full Text] [Related]
10. Effect of various cytokines and growth factors on the interleukin-2-dependent in vitro differentiation of natural killer cells from bone marrow.
Migliorati G; Cannarile L; Herberman RB; Riccardi C
Nat Immun Cell Growth Regul; 1989; 8(1):48-55. PubMed ID: 2654622
[TBL] [Abstract][Full Text] [Related]
11. Lymphokine-activated killer (LAK) cells against human leukemia: augmentation of LAK-cell cytotoxicity by combinations of lymphokines or cytokines.
Teichmann JV; Ludwig WD; Seibt-Jung H; Thiel E
Haematol Blood Transfus; 1990; 33():103-9. PubMed ID: 2182408
[No Abstract] [Full Text] [Related]
12. IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes.
Kawakami Y; Custer MC; Rosenberg SA; Lotze MT
J Immunol; 1989 May; 142(10):3452-61. PubMed ID: 2654291
[TBL] [Abstract][Full Text] [Related]
13. Human recombinant IL-4 suppresses the induction of human IL-2 induced lymphokine activated killer (LAK) activity.
Brooks B; Rees RC
Clin Exp Immunol; 1988 Nov; 74(2):162-5. PubMed ID: 3265652
[TBL] [Abstract][Full Text] [Related]
14. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells.
Chehimi J; Valiante NM; D'Andrea A; Rengaraju M; Rosado Z; Kobayashi M; Perussia B; Wolf SF; Starr SE; Trinchieri G
Eur J Immunol; 1993 Aug; 23(8):1826-30. PubMed ID: 8102101
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the antibody-dependent cytotoxic capabilities of individual human monocytes. Role of Fc gamma RI and Fc gamma RII and the effects of cytokines at the single cell level.
Connor RI; Shen L; Fanger MW
J Immunol; 1990 Sep; 145(5):1483-9. PubMed ID: 1696598
[TBL] [Abstract][Full Text] [Related]
16. Cytokine regulation of tumor necrosis factor-alpha and -beta (lymphotoxin)-messenger RNA expression in human peripheral blood mononuclear cells.
Kasid A; Director EP; Stovroff MC; Lotze MT; Rosenberg SA
Cancer Res; 1990 Aug; 50(16):5072-6. PubMed ID: 1696166
[TBL] [Abstract][Full Text] [Related]
17. Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow.
Brandt J; Srour EF; van Besien K; Briddell RA; Hoffman R
J Clin Invest; 1990 Sep; 86(3):932-41. PubMed ID: 1697607
[TBL] [Abstract][Full Text] [Related]
18. Analysis of lymphokine-activated killer (LAK) cells.
Ortaldo JR
Prog Clin Biol Res; 1987; 244():197-206. PubMed ID: 2443928
[No Abstract] [Full Text] [Related]
19. Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration.
Kleinerman ES; Knowles RD; Lachman LB; Gutterman JU
Cancer Res; 1988 May; 48(9):2604-9. PubMed ID: 3128401
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to granulocyte/macrophage colony-stimulating factor, without inducing their functional maturation.
Koch F; Heufler C; Kämpgen E; Schneeweiss D; Böck G; Schuler G
J Exp Med; 1990 Jan; 171(1):159-71. PubMed ID: 2404080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
